Is sertraline treatment or depression remission in depressed Alzheimer’s patients associated with improved caregiver wellbeing? The Depression in Alzheimer’s Disease Study 2 (DIADS-2)

OBJECTIVES: To assess if sertraline treatment (vs. placebo) or remission of depression at 12 weeks (vs. non-remission) in Alzheimer’s patients is associated with improved caregiver wellbeing. DESIGN: A randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of sertrali...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Longmire, Crystal V. Flynn, Drye, Lea T., Frangakis, Constantine E., Martin, Barbara K., Meinert, Curtis L., Mintzer, Jacobo E., Munro, Cynthia A., Porsteinsson, Anton P., Rabins, Peter V., Rosenberg, Paul B., Schneider, Lon S., Weintraub, Daniel, Lyketsos, Constantine G.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3910508/
https://ncbi.nlm.nih.gov/pubmed/24314887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jagp.2013.02.014
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky